After a series of recent acquisitions, developing a diverse portfolio comprising four business areas; including OTC and branded prescription medicines, Mylan UK’s country manager, Jean-Yves Brault, takes a step back and analyses the new Mylan, while highlighting how it is fit for the future of healthcare.
How does Mylan position itself in the market today, and how has it evolved over recent years?
"I believe we were very successful in integrating the people, processes and resources that have joined the Mylan family"
